Page
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS				12
PART I. FINANCIAL INFORMATION				3
Item 1.	Financial Statements			43
Item 2.	Management'sManagement’s Discussion and Analysis of Financial Condition and Results of Operations			124
Item 3.	Quantitative and Qualitative and Quantitative Disclosures Aboutabout Market RiskRisks			158
Item 4.	Controls and Procedures			159
PART II. OTHER INFORMATION				17
Item 1.	Legal Proceedings			1710
Item 1A.	Risk Factors		10
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds			1710
Item 3.	Defaults Upon Senior Securities			1710
Item 4.	Mine Safety DisclosureDisclosures			1710
Item 5.	Other informationInformation			1710
Item 6.	Exhibits			18
SIGNATURES				19

2

PART I – FINANCIAL INFORMATION

TABLE OF CONTENTS

Index to Financial Statements		Page11
Condensed Balance Sheets as of August 31, 2017 and November 30, 2016 (unaudited)			4
Condensed SIGNATURES			12

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

Kange Corp.

Index to Interim Financial Statements

3

Table of Contents

The accompanying notes are an integral part of these unaudited financial statements.

Item 1. Financial Statements

KANGE CORP.Kange Corp

CONDENSED BALANCE SHEETS (Unaudited)Statements of Operations

(Unaudited)

		August 31,				November 30,
		2017				2016
ASSETS
Current assets
Cash		$	77			$	155
Total current assets			77				155
Total Assets		$	77			$	155
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Convertible notes payable to related parties, net of discount		$	54,251			$	52,081
Accounts payable			-				200
Due to related party			21,919				10,250
Accrued expenses			5,082				-
Accrued expenses - related party			10,925				6,029
Total current liabilities			92,177				68,560
Total Liabilities			92,177				68,560
Stockholders' deficit
Common stock, $0.001 par value, 75,000,000 shares authorized,
10,665,000 and 10,570,000 shares issued and outstanding, respectively			10,665				10,570
Additional paid-in capital			617,158				541,253
Accumulated deficit			(719,923	)			(620,228	)
Total stockholders' deficit			(92,100	)			(68,405	)
Total liabilities and stockholders' deficit		$	77			$	155

SeeThe accompanying notes to condensedare an integral part of these unaudited financial statements.

4F-2

Table of Contents

For the Nine Months Ended August 31, 2018

For the Nine Months Ended August 31, 2017

The accompanying notes are an integral part of these unaudited financial statements.

KANGE CORP.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

		For the Three Months Ended								For the Nine Months
		August 31,								August 31,
		2017				2016				2017				2016
Revenue		$	-			$	-			$	-			$	-
Operating expenses:
General and administrative			2,049				6,140				16,629				23,503
Consulting			76,000				-				76,000				-
Total Operating Expenses			78,049				6,140				92,629				23,503
Operating loss			(78,049	)			(6,140	)			(92,629	)			(23,503	)
Other income (expense):
Interest expense			(1,642	)			(1,628	)			(4,896	)			(4,198	)
Amortization of debt discounts			-				(15,348	)			(2,170	)			(42,366	)
Total other income (expense)			(1,642	)			(16,976	)			(7,066	)			(46,564	)
Net loss		$	(79,691	)		$	(23,116	)		$	(99,695	)		$	(70,067	)
Net Income/(loss) per share - basic and diluted		$	(0.01	)		$	(0.00	)			(0.01	)			(0.01	)
Weighted average number of shares outstanding - basic and diluted			10,576,196				10,570,000				10,572,080				10,570,000

SeeThe accompanying notes to condensedare an integral part of these unaudited financial statements.

5F-4

Table of Contents

KANGE CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

		For the Nine Months Ended
		August 31,
		2017				2016
Cash flows from operating activities:
Net Income/(loss)		$	(99,695	)		$	(70,067	)
Adjustments to reconcile net loss to net cash (used in) operating activities:
Amortization of debt discount			2,170				42,366
Issuance of common stock for services			76,000				-
Changes in operating assets and liabilities
Accounts payable			(200	)			(5,632	)
Accrued expenses			5,082				-
Accrued expenses to related party			4,896				897
Net cash used in operating activities			(11,747	)			(32,436	)
Cash flows from financing activities:
Proceeds from loan from related party			11,669				6,250
Proceeds from convertible note payable to relate party			-				26,188
Net cash provided by financing activities			11,669				32,438
Net Change in Cash			(78	)			2
Cash, beginning of period			155				243
Cash, end of period		$	77			$	245
SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest		$	-			$	-
Cash paid for taxes		$	-			$	-

See accompanying notes to condensed unaudited financial statements.

6

Table of Contents

KANGE CORP.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

AUGUST 31, 20172018

(Unaudited)

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

Organization

Kange Corp. ("Kange," the "Company," "we," "us," or "our") was incorporated under the laws of the State of Nevada on August 16, 2013 (Inception).2013. We are a development stagestart-up company developing mobile software products for Apple and Android platforms, starting in Estonia and Europe, which is our initial intended market. Apple is a trademark of Apple Inc., and Android is a trademark of Alphabet Inc. During 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry.

Basis of Presentation

The accompanying unaudited condensed financial statements of Kange Corp.the Company are condensed and have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”), including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles for interim financialin the United States of America (“U.S. GAAP”), have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and the instructions to Form 10-Q and Article 8 of Regulation S-X. The results of operations for the interim period ended August 31, 2017 shown in this report are not necessarily indicative of results to be expected for the full fiscal year ending November 30, 2017. In the opinion of the Company's management, the information contained herein reflects all adjustments (consisting of normal recurring adjustments)notes necessary for a fair presentation of the Company's results of operations,comprehensive financial positionstatements and cash flows. The unaudited interim condensed financial statements should be read in conjunction with theour audited consolidated financial statements included in the Company'sour Annual Report on Form 10-K for the year ended November 30, 2016 filed on March 3, 2017 and Management's Discussion and Analysis2017. The results of Financial Condition and Resultsoperations for the period ended August 31, 2018 are not necessarily indicative of Operations.the operating results for the full year.

Fair Value of Financial Instruments

The Company measures its financial assets and liabilities in accordance with generally accepted accounting principles. For certain of our financial instruments, including cash, accounts payable, accrued expenses, and short-term loans the carrying amounts approximate fair value due to their short maturities.

The Company evaluates its convertible debt, options, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. The result of this accounting treatment is that under certain circumstances theuses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

The Company’s financial instruments, including cash, accounts payable, accrued expenses, and due to related parties are carried at historical cost. At August 31, 2018 and November 30, 2017, the carrying amounts of these instruments approximated their fair values because of the derivative is marked-to-market each balance sheet dateshort-term nature of these instruments. The Company values marketable securities as level 1 and recorded as a liability. In the event that theare measured at fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Equity instruments that are initially classified as equity that become subject to reclassification under this accounting standard are reclassified to liability at the fair value of the instrument on the reclassification date.value.

7F-5

Table of Contents

KANGE CORP.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

AUGUST 31, 2017

(Unaudited)

Going Concern

The accompanying unaudited condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company sustained net losses of $99,695 and used cash in operating activities of $11,747$1,327 for the nine months ended August 31, 2017.2018. The Company had working capital deficit, stockholders' deficit andan accumulated deficit of $92,100, $92,100 and $719,923, respectively,$1,294,913 at August 31, 2017.2018. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from thirdrelated parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts.

The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statementsstatements. The estimates and judgments will also affect the reported amounts of revenues andfor certain expenses during the reporting period. Actual results could differ from those estimates. Significantthese good faith estimates in the accompanying financial statements include the amortization period for intangible assets, valuation and impairment valuation of intangible assets, depreciable lives of the web site and property and equipment, valuation of warrants and beneficial conversion feature debt discounts, valuation of derivatives, valuation of share-based payments and the valuation allowance on deferred tax assets.judgments.

Reclassifications

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported losses, total assets, or stockholders' equity as previously reported.

Net Earnings (Loss) Per Share

In accordance with ASC 260-10, "Earnings per Share," basic net earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share areis computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Dilutive common stock equivalent sharesperiod, which may dilute future earnings per share consist of convertible notes convertible into 2,851,185 common shares. Equivalent shares are not utilized whenexcluded from the effect is anti-dilutive (see Note 3).computation if anti-dilutive. There are no dilutive or potentially dilutive securities outstanding during the periods presented.

8

Table of Contents

KANGE CORP.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

AUGUST 31, 2017

(Unaudited)

Effect of Recent Accounting Pronouncements

The Company reviews new accounting pronouncements as issued. NoExcept as disclosed in Note 2, no new pronouncements had any material effect on these unaudited financial statements. The accounting pronouncements issued subsequent to the date of these unaudited financial statements that were considered significant by management were evaluated for the potential effect on these unaudited financial statements. Management does not believe any of the subsequent pronouncements will have a material effect on these unaudited financial statements as presented and does not anticipate the need for any future restatement of these unaudited condensed financial statements because of the retro-active application of any accounting pronouncements issued subsequent to August 31, 20172018 through the date these unaudited financial statements were issued.

NOTE 2 – ASSIGNMENT OF CONTRACTUAL RIGHTSPREPAID EXPENSES

During the year ended November 30, 2017, the Company issued a total of 155,000 shares of common stock to five separate consultants pursuant to advisory board agreements. Three advisory board agreements were made effective on May 25, 2017 with terms of 15,000 shares each to be issued for one year of services to be rendered. Two advisory board agreements were made effective on October 1, 2017 with terms of 30,000 shares each to be issued for one year of services. The Company valued the advisory agreement shares based on the closing stock price of the Company on the date of the executed agreement (the grant date), which resulted in a total combined value of $124,000 initially recorded as prepaid expense to be amortized ratably over the contract term.

During the nine months ended August 31, 2018, the Company recorded consulting expense in the amount of $53,392, resulting in the remaining balance of prepaid expense, the uncompleted portion of the contract, of $12,920 and $66,312 at August 31, 2018 and November 30, 2017, respectively

NOTE 3 – MARKETABLE SECURITIES

We adopted ASU 2016-01 on December 1, 2017, which requires us to measure all equity investments that do not result in consolidation and are not accounted for under the equity method at fair value and recognize any changes in earnings. We use quoted market prices to determine the fair value of equity securities with readily determinable fair values.

On November 9, 2015, in exchange for 5,000,0001, 2017 the Company executed a stock purchase agreement (the “SPA”) with AMJ Global Entertainment, LLC, a related party and holder of 4,803,195 shares of common stock ofin Patient Access Solutions Inc., a Nevada corporation with ticker symbol “PASO”. Pursuant to the SPA, the Company the Company was assigned by AMJ Global, LLC ("AMJ Global"), a company beneficially owned by Dr. Arthur Malone, Jr., the Company's chief executive officer and director, the contractual rightsissued 158,824 shares of AMJ Global pursuant to its agreements with Blabeey,common stock in exchange for 1,157,142 shares of Patient Access Solutions Inc. ("Blabeey"), a mobile App designer focused on social media and messaging. The irrevocable assignment, transferred and conveyed in its entirety to the Company, all of AMJ Global's rights and obligations that are stipulated and set forth in every and all agreements between AMJ Global and Blabeey, including, but not limited to, the agreement between AMJ Global and Blabeey dated October 26, 2015. The transaction was, due to the structure of the agreement, between entities under common control and therefore the amount of the historical cost of the assets, $471,672, was recorded as an expense as there is no fixed and determinable future value, and the expense was recorded as a loss on the acquisition of contractual rights. See Notes 5 and 6.

NOTE 3 – CONVERTIBLE NOTES PAYABLE TO RELATED PARTIES, NET OF DISCOUNTS

Convertible notes payable, net of discounts, all classified as current at August 31, 2017 and November 30, 2016, consists of the following:

Convertible notes to related parties, net of discounts

		August 31, 2017												November 30, 2016
										Principal,												Principal,
						Debt				net of								Debt				net of
		Principal				Discount				Discounts				Principal				Discount				Discounts
AMJ Global, LLC (a)		$	9,935			$	-			$	9,935			$	9,935			$	-			$	9,935
AMJ Global, LLC			18,128				-				18,128				18,128				-				18,128
AMJ Global, LLC			19,901				-				19,901				19,901				-				19,901
AMJ Global, LLC			6,287				-				6,287				6,287				(2,170	)			4,117
Total		$	54,251			$	-			$	54,251			$	54,251			$	(2,170	)		$	52,081

_________

(a) Assigned from Victor Stepanov on March 15, 2016.

On November 9, 2015,1, 2017, the Company executed a convertible promissory note with Victor Stepanov,recorded the former chief executive officer and directorshares of the Company, for $9,935, in exchange for accrued compensation pursuant to his employment agreement with the Company. The note bears interestPatient Access Solutions Inc. at the rate of 12% per annum, which accrues monthly.$81,000. As of August 31, 2017 and November 30, 2016,2018, based quoted market prices, the accrued interest was $2,162 and $1,265, respectively. The note matured on November 8, 2016. The note has a conversion featureCompany recognized an unrealized loss of $0.02 per share. A beneficial conversion feature of $9,935 was recorded and was accreted monthly from the issuance date of the note through maturity. As of August 31, 2017 and November 30, 2016, $9,935 and $9,935, respectively, has been recorded as a beneficial conversion feature expense. On March 15, 2016, Mr. Stepanov assigned this convertible promissory note to AMJ Global, LLC ("AMJ Global"). See Notes 5 and 6.$64,800.

9

Table of Contents

The carrying values and unrealized loss of our equity securities were included in the following line items in our balance sheets and statements of operations:

KANGE CORP.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

AUGUST 31, 2017

(Unaudited)

On November 9, 2015, the Company executed a convertible promissory note with AMJ Global, a company which is beneficially owned by Dr. Arthur Malone, Jr., the chief executive officer and director of the Company, for $18,128. This note was created due to the assignment of the balance due to shareholder (see Note 5), which was assigned to AMJ Global on November 9, 2015. The note bears interest at the rate of 12% per annum, which accrues monthly. As of August 31, 2017 and November 30, 2016, the accrued interest was $3,946 and $2,310, respectively. The note matured on November 8, 2016. The note has a conversion feature of $0.02 per share. A beneficial conversion feature of $18,128 was recorded and was accreted monthly from the issuance date of the note through maturity. As of August 31, 2017 and November 30, 2016, $18,128, respectively, has been recorded as a beneficial conversion feature expense. See Note 5.

On February 5, 2016, the Company executed a convertible promissory note with AMJ Global for $19,901. This note was in exchange for the payment of certain vendors of the Company. The note bears interest at the rate of 12% per annum, which accrues monthly. As of August 31, 2017 and November 30, 2016, the accrued interest was $3,756 and $1,960. The note matured on February 4, 2017. The note has a conversion feature of $0.02 per share. A beneficial conversion feature of $19,901 was recorded and was accreted monthly from the issuance date of the note through maturity. As of August 31, 2017, $19,901 has been recorded as a beneficial conversion feature expense. See Note 5.

On April 6, 2016, the Company executed a convertible promissory note with AMJ Global for $6,287. This note was in exchange for the payment of certain vendors of the Company. The note bears interest at the rate of 12% per annum, which accrued monthly. As of August 31, 2017 and November 30, 2016, the accrued interest was $1,061 and $493. The note matured on April 6, 2017. The note has a conversion feature of $0.02 per share. A beneficial conversion feature of $6,287 was recorded and was accreted monthly from the issuance date of the note through maturity. As of August 31, 2017, $6,287 has been recorded as a beneficial conversion feature expense. See Note 5.

NOTE 4 – COMMITMENTS AND CONTINGENCIES

Legal Matters

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of August 31, 2017, there were no pending or threatened lawsuits.

NOTE 5 – RELATED PARTY TRANSACTIONS

In support of the Company's efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are non-interest bearing, considered temporary in nature, and have not been formalized by a promissory note.

On August 16, 2013, our sole director and principal shareholder advanced $678 toNovember 1, 2017, the Company to fund its initial incorporation with the Nevada Secretary of State. The sole director and principal shareholder loanedentered into a further $500 to the Company on October 30, 2013 as working capital. During October 2014, a director had loaned $10,300 to the Company for working capital. During the fiscal year 2015, through November 9, 2015, an additional $6,650 was loaned to the Company. On November 9, 2015, the total for the loan from this director was $18,128 and it was assigned to AMJ Global, a company controlled by Dr. Arthur Malone, Jr., the Company's chief executive officer and director. The Company executed a convertible note payable to AMJ Global for $18,128. This note was created due to the assignment of the balance due to shareholder (see Note 3), which was assigned to AMJ Global on November 9, 2015.

10

Table of Contents

KANGE CORP.

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

AUGUST 31, 2017

(Unaudited)

On February 5, 2016, the Company executed a convertible promissory noteone-year office lease agreement with AMJ Global for $19,901. This note was in exchange forEntertainment LLC, a related party controlled by the payment of certain vendorsCompany’s CEO and director, ending November 2, 2018. The location of the Company.leased office space is 11724 Ventura Blvd Suite B, Studio City, California 91604. The note bears interest at the ratelease states monthly rent due of 12% per annum, which accrues monthly. The note matured on June 8, 2016. The note has a conversion feature of $0.02 per share. See Note 3.

On March 15, 2016, Mr. Stepanov assigned his convertible promissory note to AMJ Global. See Note 3. 

On April 6, 2016, the Company executed a convertible promissory note with AMJ Global for $6,287. This note was in exchange for the payment of certain vendors of the Company. The note bears interest at the rate of 12% per annum, which accrued monthly. The note matured on April 6, 2017. The note has a conversion feature of $0.02 per share. See Note 3.

In$1,000. During the nine months ended August 31, 2017,2018, the Company had $11,669 of general and administrative expenses paid by AMJ Global, a company beneficially owned by Dr. Arthur Malone, Jr., the chief executive officer and director of the Company.accrued $9,000 due to related party. As of August 31, 20172018 and November 30, 2016,2017, the Company hadhas accrued expenses to related party balances of $10,925 and $6,029 as well as alease expense due to related party balance of $21,919$6,000 and 10,250.$1,000, respectively.

NOTE 6 – STOCKHOLDERS' DEFICITAt November 30, 2017, the Company owed $26,901 to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director. The amount is unsecured, non-interest bearing and due on demand. During the nine months ended August 31, 2018 and 2017, the Company received proceeds of $1,250 and $11,669, respectively, from the related party. On March 5, 2018, the Company settled the loans totaling $28,151 plus $4,000 of accrued related party lease expense by the issuance of 387,623 shares of common stock valued at $484,529. As a result, the Company recorded a loss on settlement of debt of $452,378.

NOTE 5 – COMMON STOCK

Common Stock

The Company washas authorized to issue up to 75,000,000common shares of common stock,750,000,000, par value $0.001 per share. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights.

In the nine months ended August 31, 2017,On March 5, 2018, the Company issued 95,000387,623 shares of common stock valued at $484,529 to four consultants pursuantsettle debt of $32,151 owed to four advisory board agreements. The Company valued the shares issued to consultants at the closing stock price of the Company which resulted in the Company recording a consulting expense of $76,000. related party (Note 3).

There were 10,665,00014,553,465 and 14,165,842 shares of common stock issued and outstanding as of August 31, 2017.2018 and November 30, 2017, respectively.

NOTE 76 – SUBSEQUENT EVENTS

ManagementOn January 13, 2020, the transaction related to stock purchase agreement with AMJ Global Entertainment, LLC, a related party and holder of 4,803,195 shares of common stock in Patient Access Solutions Inc. (see Note 2), was rescinded, and the Company will return 1,157,142 shares of Patient Access Solutions Inc. back to AMJ Global Entertainment, LLC in exchange for 157,142 shares of the Company.

The Company has evaluated subsequent events pursuantoccurring subsequent to the requirements of ASC Topic 855balance sheet date through the date these financial statements were issued, and has determined that other than listed below,there are no material subsequentadditional events exist.requiring disclosure.

1.

In September of 2017, the Company issued 3,283,700 shares of common stock to a related party for the conversion of outstanding debt.

11F-7

Table of Contents

ITEMItem 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

SPECIAL NOTE CONCERNING FORWARD-LOOKING STATEMENTS

We believe that it is important to communicate our future expectations to our security holders and to the public. This report, therefore, contains statements about future events and expectations which are "forward-looking statements" within the meaning of Sections 27A of the Securities Act of 1933 and 21E of the Securities Exchange Act of 1934, including the statements about our plans, objectives, expectations and prospects under the heading "Management'sManagement’s Discussion and Analysis of Financial Condition and Results of Operations." You can expect to identify theseOperations

This Quarterly Report on Form 10-Q contains forward-looking statements by forward-looking words suchwithin the meaning of Rule 175 of the Securities Act of 1933, as "may," "might," "could," "would," "will," "anticipate," "believe," "plan," "estimate," "project," "expect," "intend," "seek"amended, and other similar expressions. Any statement contained in this reportRule 3b-6 of the Securities Act of 1934, as amended, that is not a statement of historical fact may be deemed to be a forward-looking statement. Although we believe that the plans, objectives, expectationsinvolve substantial risks and prospects reflected in or suggested by ouruncertainties. These forward-looking statements are reasonable, thosenot historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as “anticipate,” “expects,” “intends,” “plans,” “believes,” “seeks” and “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements involveare not guarantees of future performance and are subject to risks, uncertainties and other factors, that maysome of which are beyond our control and difficult to predict and could cause our actual results performance or achievements to bediffer materially different from any future results, performance or achievementsthose expressed or implied byforecasted in the forward-looking statements. You should not place undue reliance on these forward-looking statements, and we can give no assurance that our plans, objectives, expectations and prospects will be achieved.

which apply only as of the date of this Form 10-Q. Investors should carefully consider all of such risks before making an investment decision with respect to the Company’s stock. The following discussion of our results of operationsand analysis should be read togetherin conjunction with our financial statements and related notes included elsewhere in this report.summary of selected financial data for Kange Corp. Such discussion represents only the best present assessment from our Management.

GeneralCompany Overview

The Company wasKange Corp., a startupNevada corporation (the “Company,” “Kange,” “we,” and “us”), is an early-stage company that was incorporated in Nevada on August 16, 2013.

The Company ishas historically focused on developing and marketing a software product as a mobile applicationapplications for end users of the current generation iPhone and iPad from Apple, Inc., and mobile phones using the Android platform. The mobile application's digital content will be customizable bySince 2017, the owner of the particular device using our software. We plan to stayCompany has been focusing on the cutting edgeintersection of technology and wholistic technology-based health treatments, with the constantly changing mobile application market, and our goal is to create a quality reputation within the mobile software community and marketplace. We plan to sell our initial applications through Apple's App Store or through our own online retail website to small business owners, who desire their own mobile applications and want to control the content. Apple, App Store, iPhone and iPad are trademarks of Apple Inc., and Android and Google Play are trademarks of Alphabet Inc.

On June 8, 2015, the Company entered into a development contract with Idap Group, LTD, a Ukrainian company ("Software Developer"). Under the terms of the contract, Software Developer agreedintention to provide mobile (pdaservices to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and smartphone) application ("App") software development to the early onset of dementia and Alzheimer’s. The Company in exchange for not more than one hundred thousand U.S. dollars. Delivery of the ready software shall be performed by placing itis currently evaluating operations in the App Store and Google Play by Software Developer or transmitted via the Internet.wholistic health industry.

On November 9, 2015, AMJ Global, LLC ("AMJ Global"), a company beneficially owned by Dr. Arthur Malone, Jr., the Company's chief executive officer and director, assigned the rights of AMJ Global pursuant to its agreements with Blabeey, Inc. ("Blabeey"), a mobile App designer. The irrevocable assignment, transferred and conveyed in its entirety to the Company in a common control transaction, all of AMJ Global's rights and obligations that are stipulated and set forth in every and all agreements between AMJ Global and Blabeey, including, but not limited to, the agreement between AMJ Global and Blabeey dated October 26, 2015. Blabeey's web site is www.blabeey.com, andwhich is not incorporated in this filing. The Company issued 5,000,000 shares of common stock to AMJ Global for the assignment. The Company valued those shares at $471,672, the historical asset costs of Blabeey. Since the Company’s transaction with AMJ Global was between entities under common control, the amount of the historical cost of Blabeey.the assets, $471,672, was recorded as an expense in 2015 as there was no fixed and determinable future value, and the expense was recorded as a loss on the acquisition of contractual rights. Subsequently, the Company began working with Blabeey on developing technology for social media regarding Autism, PTSD and other neurological issues, and the Company is still consulting with Blabeey regarding software development opportunities in connection with the wholistic health industry.

In May of 2017, the Company retained Bruce Weitzberg to serve on the Company’s Board of Advisors and advise the Company regarding the intersection of technology and wholistic health care treatment and healthy living. Mr. Weitzberg is the CEO of Patient Access Solutions Inc., a Nevada corporation with ticker symbol “PASO” (“PASO”). PASO is a provider of healthcare and financial processing solutions for the healthcare and dental industries, and it has also opened a new center for the treatment of individuals with autism spectrum disorder and other biomedical conditions.

Subsequently, the Company retained James Lantiegne, a professional magician and former COO and CFO of a national software company, to serve on the Company’s Board of Advisors and provide the Company advice on the intersection of technology and health. In October of 2017, the Company retained Benny Malone, former NFL running back for the Miami Dolphins and Washington Redskins, and Eric Metcalf, former NFL running back, wide receiver and three-time Pro-Bowl selection, to serve on the Company’s Board of Advisors and advise the Company regarding sports health issues and treatments.

On November 1, 2017, the Company executed a stock purchase agreement (the “SPA”) with AMJ Global Entertainment, LLC, another related party company controlled by our CEO and director, Dr. Arthur Malone, Jr., to purchase 1,157,142 shares of Patient Access Solutions Inc., a Nevada corporation with ticker symbol “PASO” (“PASO”), in consideration of the issuance of 158,824 shares of our common stock. PASO is a provider of healthcare and financial processing solutions for the healthcare and dental industries, and it has also opened a new center for the treatment of individuals with autism spectrum disorder and other biomedical conditions. The Company is currently advising PASO on formulating a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating wholistic technology-based healthcare treatments, and is evaluating potential additional operations in the wholistic health industry. On January 13, 2020, the transaction was rescinded, and the Company will return 1,157,142 shares of Patient Access Solutions Inc. back to AMJ Global Entertainment, LLC in exchange for 157,142 shares of the Company.

We have had limited operations and have been issued a "going concern" opinion by our auditor for the period endedon our November 30, 2016,2017 audited financial statements, based upon our reliance on related party loans and the sale of our common stock as the sole sourcesources of funds for our operations for the near future.

Reports to Security Holders

The Company is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, and is a “voluntary filer.” As a voluntary filer, the Company intends to furnish its stockholders with annual reports containing financial statements audited by its independent registered public accounting firm and to make available quarterly reports containing unaudited financial statements for each of the first three quarters of each year, but is not obligated to do so. The Company files Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K with the Securities and Exchange Commission. The Company may also file additional documents with the Commission if those documents become necessary in the course of its operations.

Available Information

All reports of the Company filed with the SEC are available free of charge through the SEC’s website at www.sec.gov. In addition, the public may read and copy materials filed by the Company at the SEC’s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549. The public may also obtain additional information on the operation of the Public Reference Room by calling the Commission at 1-800-SEC-0330.

Results of Operations

The following Management Discussiondiscussion and Analysisanalysis of our financial condition and results of operations should be read in conjunction with the unaudited financial statements and accompanying notes included in this Form 10-Q.thereto for the three and nine months ended August 31, 2018 and 2017, and related management discussion herein.

Our financial statements are stated in U.S. Dollars and are prepared in accordance with generally accepted accounting principles of the United States (“GAAP”).

Going Concern Qualification

Several conditions and events cast substantial doubt about the Company’s ability to continue as a going concern. The Company has incurred cumulative net losses of $1,294,913 since its inception and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to raise additional capital through debt or future issuances of capital stock is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raises substantial doubt about the Company’s ability to continue as a going concern.

Results of Operations

For the Three Month PeriodMonths Ended August 31, 2017 Compared to the Three Month Period Ended August 31, 2016.2018 and 2017:

We recognized no revenue

Our operating results for the three months ended August 31, 2018 and 2017, and 2016the changes between those periods for the respective items, are summarized as we are a development stage company.follows:

During the three months endedending August 31, 2017, we incurred general2018 the Company had an operating loss of $15,399 and administrative expensesrecognized an unrealized loss on marketable securities of $2,049 compared$28,929 due to $6,140 incurredrevaluation of marketable securities. For the same period in the prior fiscal year, the Company recorded an operating loss of $78,049 and interest expense of $1,642. The decrease in operating loss during the three months ended August 31, 2016. These expenses related to corporate overhead, financial and administrative contracted services. The variance2018, is primarily due to timing of services rendered in connection with the Company's filings.

During the three months ended August 31, 2017, we incurred consulting expenses of $76,000 compared to $0 incurred during the three months ended August 31, 2016. The expense was related to2017.

For the issuance of stock pursuant to advisory board agreements with four individuals.

Our net loss for the three months period ended August 31, 2017 was $79,691 compared to a net loss of $23,116 for the three months period ended August 31, 2016 due to the factors discussed above, including $15,348 of amortization of debt discount for 2016.

Nine Month PeriodMonths Ended August 31, 2017 Compared to the Nine Month Period Ended August 31,, 2016.2018 and 2017:

We recognized no revenueOur operating results for the nine months ended August 31, 2018 and 2017, and 2016the changes between those periods for the respective items, are summarized as we are a development stage company.follows:

Revenues

We did not earn any revenues during the nine months ending August 31, 2018 or 2017.

Operating Loss

Our loss from operations decreased to $69,475 during the nine months ending August 31, 2018, from an operating loss of $92,629 in the comparative period ending August 31, 2017. The following table presents operating expenses for the nine-month periods ending August 31, 2018 and 2017:

The Company recorded $53,392 in consulting fees during the nine months ended August 31, 2018, as compared to $76,000 for the same period in the prior fiscal year, due to signed advisory board agreements. We realized a decrease of $546 in general and administrative expenses during the nine months ended August 31, 2018, as compared to the same period in the prior fiscal year.

Other Income (Expense)

The following table presents other income and expenses for the nine months ended August 31, 2018 and 2017:

During the nine months ending August 31, 2018 the Company recognized loss on debt settlement of $452,378 due to shares issued for debt to related party. During the nine months ending August 31, 2018 the Company recognized an unrealized loss on marketable securities of $64,800 due to revaluation of marketable securities. For the same period in the prior fiscal year, the Company recorded interest expense of $4,896, and amortization of debt discount of $2,170.

Net Loss

The Company incurred a $586,653 net loss during the nine months ended August 31, 2018, compared to net loss of $99,695 in the same period in the prior fiscal year. This is primarily due to loss on settlement of debt, and unrealized loss on marketable securities recognized during the 2018 period.

Liquidity and Capital Resources

Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all.

Working Capital

The following table presents our working capital position as of August 31, 2018 and November 30, 2017:

The change in working capital during the nine months ended August 31, 2018, was primarily due to a decrease in current assets of $118,269 and a decrease in current liabilities of $16,145. Current assets decreased primarily due to revaluation of investment in marketable securities and amortization of prepaid consulting expense. Current liabilities decreased primarily due to debt settlement to related party of $32,151. Cash reduced as of August 31, 2018, by $77 to $0.

Cash Flow

We fund our operations with cash received from advances from officers and related parties and issuances of equity.

The following tables presents our cash flow for the nine months ended August 31, 2018 and 2017:

Cash Flows from Operating Activities

We did not generate positive cash flows from operating activities for the nine months ended August 31, 2018 or 2017.

For the nine months ended August 31, 2018, net cash flows used in operating activities consisted of a net loss of $586,653, reduced by unrealized loss on marketable securities of $64,800, loss on settlement of debt of $452,378 and by a net increase in change of operating assets and liabilities of $68,148.

For the nine months ended August 31, 2017, we incurred generalnet cash flows used in operating activities consisted of a net loss of $99,695, reduced by amortization of debt discount of $2,170, issuance of common stock for consulting services valued at $76,000 and administrative expensesnet change in operating assets and liabilities of $16,629 compared to $23,503 incurred during$9,778.

Cash Flows from Investing Activities

For the nine months ended August 31, 2016. These expenses related to corporate overhead, financial2018 and administrative contracted services. The variance is due to timing of services rendered2017, no cashflows were provided by or used in connection with the Company's filings.investing activities.

DuringCash Flows from Financing Activities

For the nine months ended August 31, 2018 and 2017, we incurred consulting expenses of $76,000 comparedreceived $1,250 and $11,669, respectively, in advances from related parties, which were used to $0 incurred during the nine months ended August 31, 2016. The expense was related to the issuance of stock pursuant to advisory board agreements with four individuals.fund operations and business activities.

Our net loss for the nine months period ended August 31, 2017 was $99,695 compared to a net loss of $70,067 for the nine months period ended August 31, 2016 due to the factors discussed above, including $2,170 of amortization of debt discount for 2017.

Liquidity and Capital Resources

As of August 31, 2017, our total assets were $77, comprising exclusively of cash, compared to $155 in total assets, also comprising exclusively of cash, at November 30, 2016.

As of August 31, 2017, our total liabilities were $92,177, which included accounts payable, accrued expenses, and notes payable to related parties, compared to $68,560 in total liabilities, which included accounts payable, accrued expenses, and notes payable to related parties, at November 30, 2016.

Stockholders' deficit was $92,100 as of August 31, 2017 compared to stockholders' deficit of $68,405 as of November 30, 2016.

The variance between August 31, 2017 and November 30, 2016 principally relates to operating losses incurred in the period.

13

Table of Contents

Cash Flows from Operating Activities

Net cash used in operating activities was $11,747 and $32,436 in the nine months ended August 31, 2017 and 2016, respectively. The decrease was primarily due to the increase in payables and accrued expenses between the two periods.

Cash Flows from Investing ActivitiesOff-Balance Sheet Arrangements

The Company has not generated or used any cash flows from investing activities during the nine months ended August 31, 2017 and 2016.

Cash Flows from Financing Activities

We have historically financed our operations primarily from either advances from our shareholder or the issuance of equity. We received $11,669 and $32,438 in advances from our shareholder and issuance of convertible note to related parties during the nine months ended August 31, 2017 and 2016, respectively.

Going Concern

The accompanying unaudited condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company sustained net losses of $99,695 and used cash in operating activities of $11,747 for the nine months ended August 31, 2017. The Company had working capital deficit, stockholders' deficit and accumulated deficit of $92,100, $92,100 and $719,923, respectively, at August 31, 2017. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from third parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts.

Plan of Operation and Funding

We expect that working capital requirements will continue to be funded through a combination of loans from our director and further issuances of securities. Our working capital requirements are expected to increase in line with the growth of our business.

Off-Balance Sheet Arrangements

As of the date of this Quarterly Report, we dodoes not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on ourthe Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

14

Table of Contents

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Such estimates and assumptions affect the reported amounts of revenues and expenses during the reporting period. We base our estimates on historical experiences and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions and conditions. We continue to monitor significant estimates made during the preparation of our financial statements. On an ongoing basis, we evaluate estimates and assumptions based upon historical experience and various other factors and circumstances. We believe our estimates and assumptions are reasonable in the circumstances; however, actual results may differ from these estimates under different future conditions.

See Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Note 2, "Summary of Significant Accounting Policies" in our audited financial statements for the year ended November 30, 2016, included in our Annual Report on Form 10-K as filed on March 3, 2017, for a discussion of our critical accounting policies and estimates.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKRISK.

As a "smaller reporting company" as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.Not Applicable.

ITEM 4. CONTROLS AND PROCEDURESPROCEDURES.

Evaluation of Disclosure Controls and Procedures

The Securities and Exchange Commission defines the term "disclosure“disclosure controls and procedures"procedures” to mean a company'sthe company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission'sCommission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer'sissuer’s management, including its chiefprincipal executive and chiefprincipal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a simple system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC'sSEC’s rules and forms and that information required to be disclosed is accumulated and communicated to the chiefprincipal executive and interim chiefprincipal financial officerofficers to allow timely decisions regarding disclosure.

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officerchief executive officer and Chief Financial Officer,chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, the Chief Executive Officerour chief executive officer and Chief Financial Officer havechief financial officer concluded that the Company'sour disclosure controls and procedures arewere not effective to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified. Our chief executive officer and chief financial officer also concluded that our disclosure controls and procedures were not effective as of such date. The Chief Executive Officer and Chief Financial Officer have determined that the Company continuesend of the period covered by this report to haveprovide reasonable assurance of the following deficiencies which represent a material weakness:achievement of these objectives.

1.	The Company intends to appoint additional independent directors;
2.	Lack of in-house personnel with the technical knowledge to identify and address some of the reporting issues surrounding certain complex or non-routine transactions. With material, complex and non-routine transactions, management has and will continue to seek guidance from third-party experts and/or consultants to gain a thorough understanding of these transactions;
3.	Insufficient personnel resources within the accounting function to segregate the duties over financial transaction processing and reporting;
4.	Insufficient written policies and procedures over accounting transaction processing and period end financial disclosure and reporting processes.

15

Table of Contents

To remediate our internal control weaknesses, management intends to implement the following measures:

	·	The Company will add sufficient number of independent directors to the board and appoint additional member(s) to the Audit Committee.
	·	The Company will add sufficient accounting personnel to properly segregate duties and to effect a timely, accurate preparation of the financial statements.
	·	The Company will hire staff technically proficient at applying U.S. GAAP to financial transactions and reporting.
	·	Upon the hiring of additional accounting personnel, the Company will develop and maintain adequate written accounting policies and procedures.

The additional hiring is contingent upon The Company's efforts to obtain additional funding through equity or debt and the results of its operations. Management expects to secure funds in the coming fiscal year but provides no assurances that it will be able to do so.

Changes in Internal Control over Financial Reporting

There waswere no changechanges in the Company'sCompany’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the periodquarter ended August 31, 2017,2018, that hashave materially affected, or isare reasonably likely to materially affect, the Company'sCompany’s internal control over financial reporting.

Limitations on the Effectiveness of Controls

The Company's management, including the CEO and CFO, does not expect that our disclosure controls and procedures or our internal control over financial reporting, when implemented, will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Further, the design of the control system must reflect that there are resource constraints and that the benefits must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

169

Table of Contents

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGSPROCEEDINGS.

ManagementThe Company is not aware ofa party to any significant pending legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report,than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is (i) a party adverse to usthe Company or has a material interest adverse to the Company in any legal proceeding, or (ii) has an adverse interestreference to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us or our properties.litigation.

ITEM 1A. RISK FACTORS.

Not applicable.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no unregistered sales of equity securities during the quarterly period ending August 31, 2017.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

We have no senior securities outstanding in any of the periods presented in these financial statements.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable to our Company.

ITEM 5. OTHER INFORMATIONPROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS.

ITEM 6. EXHIBITS

See the Exhibit Index following the signature page of this Registration Statement, which Exhibit Index is incorporated herein by reference.

NumberExhibit		Description
3.1		Articles of Incorporation (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
3.2		Bylaws (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
5.1		Opinion re: Legality and Consent of Counsel (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
10.1		Agreement executed by Audit for the Period Ended November 6, 2014 of Kange Corp., the private company (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
10.2		Verbal Agreement executed: description of material loan from Mr. Brakin to Kange Corp. (incorporated by reference to our Registration Statement on Form S-1, filed on February 21, 2014)
10.3		Assignment of Rights Agreement between the Company and AMJ Global (incorporated by reference to our Current Report on Form 8-K filed on November 12, 2015)
31.1 (1)31.1*		Certification of Principal Executive Officer of Kange Corp.CEO required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 (1)32.1*		Certification of Principal Accounting Officer of Kange Corp. required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 (1)		Certification of Principal Executive Officer of Kange Corp.CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 Ofof 18 U.S.C. 63
32.2 (1)		Certification of Principal Accounting Officer of Kange Corp. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 Of 18 U.S.C. 63
101.INS101.INS**		XBRL Taxonomy Extension Instance Document
101.SCH
101.SCH**		XBRL Taxonomy Extension Schema Document
101.CAL
101.CAL**		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
101.DEF**		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
101.LAB**		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document
101.PRE**		XBRL Taxonomy Extension Presentation Linkbase Document